Myocarditis: History and Discovery

Myocarditis means inflammation of the heart muscle (the myocardium). The history of the word is far tidier than the history of the idea: the German physician Joseph Friedrich Sobernheim coined the term around 1837, and Rudolf Virchow helped popularize it after 1858 — but for most of the nineteenth and early twentieth centuries "myocarditis" was wildly over-used as a catch-all label for almost any non-valvular heart trouble, including conditions we now call hypertensive and ischemic heart disease. The real story is one of narrowing a vague word into a precise diagnosis: Carl Ludwig Alfred Fiedler's description of acute isolated myocarditis (1899), the mid-twentieth-century untangling of myocarditis from the newly named "cardiomyopathy" (Brigden, 1957), the recognition of viral causes such as the Coxsackie B enteroviruses, and finally the 1987 Dallas criteria, which fixed a standard, biopsy-based definition. This page presents that long over-diagnosis problem honestly, and flags where the historical record is genuinely uncertain.

Table of Contents

  1. What Myocarditis Means
  2. Coining the Term: Sobernheim and Virchow
  3. The Catch-All Era: A Word That Meant Too Much
  4. Fiedler and Acute Isolated Myocarditis (1899)
  5. Untangling Myocarditis from Cardiomyopathy
  6. Finding the Cause: The Viral Era
  7. Standardizing Diagnosis: The Dallas Criteria (1987)
  8. Toward the Modern Picture
  9. Research Papers and References
  10. Connections

What Myocarditis Means

Myocarditis is inflammation of the myocardium, the thick muscular middle layer of the heart wall that does the actual work of pumping blood. The name is built from Greek roots — myo- (muscle), kardia (heart), and the suffix -itis (inflammation) — so it literally reads "inflammation of the heart muscle." That is a precise anatomical claim, and grasping it is the key to the whole tangled history that follows: a true myocarditis diagnosis asserts that the heart muscle itself is inflamed, as distinct from the valves (endocarditis), the outer sac (pericarditis), or the coronary arteries that feed the muscle.

The trouble, for most of medical history, was that doctors could not actually see the inflamed muscle in a living patient. They could feel an irregular or feeble pulse, hear an abnormal heart sound, watch a young person die suddenly of heart failure, and — only after death — open the chest and inspect the heart. A boggy, dilated, failing heart at autopsy could result from many different diseases that looked alike to the naked eye. Because the label "myocarditis" sounded like a mechanism but rested on guesswork, it became a convenient catch-all, and the work of the last two centuries has been to give it a real, testable definition.

Today myocarditis is understood as a specific pathological process — inflammatory cells infiltrating the myocardium and damaging or killing heart-muscle cells — most often triggered by a viral infection, but also by other infections, autoimmune disease, certain drugs and toxins, and reactions to some medications. It can be mild and self-limiting or, in its fulminant form, rapidly fatal. The story of how medicine moved from a vague nineteenth-century word to this defined disease is the subject of this page.

Back to Table of Contents

Coining the Term: Sobernheim and Virchow

The clinical descriptions almost certainly predate the word. Accounts of what was probably inflammatory heart disease can be traced back centuries, but the term "myocarditis," coined to name an inflammatory process of the heart muscle, is most commonly credited to the German physician Joseph Friedrich Sobernheim, who introduced it around 1837 (in his work on the practical diagnosis of internal diseases). Several modern historical reviews repeat this attribution, and it is the version recorded in widely cited reference summaries of the disease's history.

The term was then carried into the medical mainstream by one of the towering figures of nineteenth-century medicine. Rudolf Virchow — the founder of cellular pathology — is generally credited with helping to popularize "myocarditis" from 1858 onward, the year his landmark work on cellular pathology appeared. With Virchow's authority behind it, the word entered routine use across European medicine. That very success, ironically, is what set up the problem described in the next section: a memorable, authoritative-sounding label spread far faster than any reliable way to confirm what it was supposed to describe.

A word of honest caution is owed here. Attributions of who "first" coined a medical term are notoriously slippery, because earlier or parallel uses can lurk in older texts and because nineteenth-century terminology shifted between languages. The Sobernheim-1837 and Virchow-1858 framing is the account given in the standard secondary literature and is presented here as the best-supported version — not as a claim that no one ever wrote a similar word earlier. Where this page states a "first," it reflects the consensus of the cited reviews.

Back to Table of Contents

The Catch-All Era: A Word That Meant Too Much

For roughly the next hundred years, "myocarditis" suffered from the opposite of obscurity: it was diagnosed everywhere, often wrongly. Through the nineteenth and into the early twentieth century the label became a catch-all for a great many non-valvular heart conditions whose true nature was not yet understood. Hearts that were enlarged, weak, or failing for reasons that had nothing to do with inflammation were routinely filed under "myocarditis" simply because no better explanation — and no test to distinguish the causes — existed.

The clearest examples come from diseases that were later given their own, correct names. Much of what physicians of that era called "chronic myocarditis" was, in modern terms, hypertensive heart disease (heart damage from long-standing high blood pressure) or ischemic heart disease (damage from narrowed coronary arteries and heart attacks). These are not inflammatory diseases at all, yet for decades they were swept into the myocarditis category. The result was a diagnosis so broad that it was nearly meaningless: it described the heart's appearance of weakness rather than any specific cause.

This over-diagnosis is not a footnote to be glossed over; it is central to understanding the field. It meant that old statistics about "myocarditis" cannot be trusted to mean what the word means today, and it meant that genuine, narrowly-defined myocarditis was hidden inside a haystack of misclassified heart failure. The intellectual project of the twentieth century was therefore largely subtractive — stripping away everything that was not true inflammation of the heart muscle until a precise core remained.

Back to Table of Contents

Fiedler and Acute Isolated Myocarditis (1899)

A decisive step toward a sharper definition came from the German physician Carl Ludwig Alfred Fiedler (1835–1921), chief of internal medicine at the Dresden-Friedrichstadt municipal hospital. In 1899 he described a distinct and dramatic condition: an acute, often rapidly fatal heart failure striking previously healthy young people, who collapsed with fever in the absence of any coronary, valvular, or pericardial disease, and whose heart muscle — examined under the microscope after death — showed inflammatory infiltration that spared the other organs. He called it acute interstitial myocarditis; it has been known ever since as Fiedler's myocarditis, or acute isolated (idiopathic) myocarditis. (Some sources date the description to 1900, the year of a key publication; the classic citation and most reviews use 1899, which this page follows while noting the discrepancy.)

Fiedler's contribution was conceptual as much as descriptive. By insisting on a case in which the heart muscle was inflamed and nothing else was demonstrably wrong, he carved out a clean, "isolated" form of the disease that could not be explained away as a complication of valve disease, narrowed arteries, or infection elsewhere in the body. This was the antidote to the catch-all problem: a recognizable entity with strict boundaries. Re-examination of his original tissue sections by the pathologist Schmorl later showed that the cases included both lymphocyte-rich and giant-cell forms — an early hint that "Fiedler's myocarditis" was a family of related processes rather than one single disease.

Remarkably, Fiedler also reasoned toward the cause. He postulated that this isolated cardiac inflammation might be driven by an invisible microorganism — an agent too small to see with the microscopes of his day. This was an explicit hypothesis, and it should be read as one, but it was a prescient one: decades later, the unseen culprits in many such cases would indeed be identified as viruses. Fiedler did not prove a viral cause; he proposed it, and the proof had to wait for twentieth-century virology.

Back to Table of Contents

Untangling Myocarditis from Cardiomyopathy

Even after Fiedler, a large grey zone remained: many cases of chronically enlarged, failing hearts of unknown cause were still loosely called "myocarditis" without any evidence of inflammation. The crucial conceptual fix arrived in 1957, when the British cardiologist Wallace Brigden introduced the term "cardiomyopathy" in a landmark two-part article in The Lancet, "Uncommon myocardial diseases: the non-coronary cardiomyopathies." Brigden used the new word to name primary diseases of the heart muscle that were not caused by coronary artery disease — and, crucially, were not necessarily inflammatory.

This new vocabulary did important housekeeping. "Cardiomyopathy" gave physicians a place to put heart-muscle disease of unknown cause without implying inflammation, which let the word "myocarditis" retreat to its proper, narrower meaning: heart-muscle disease that is genuinely inflammatory. The two terms describe overlapping territory — an episode of inflammatory myocarditis can heal into a dilated, weakened heart that is then classified as a cardiomyopathy — but separating the names was a prerequisite for clear thinking. Modern classifications continue to recognize this relationship, with "inflammatory cardiomyopathy" serving as a bridge term for myocarditis that has led to lasting cardiac dysfunction.

The disentangling of these two words is, in a sense, the climax of the over-diagnosis story. Once "cardiomyopathy" existed to absorb the non-inflammatory cases, and once tools to demonstrate inflammation were emerging, "myocarditis" could finally be held to a strict standard: show the inflammation, or do not use the word.

Back to Table of Contents

Finding the Cause: The Viral Era

Fiedler's hunch about an invisible agent was vindicated in the middle of the twentieth century, when the new science of virology began to identify the microbes behind many cases of acute myocarditis. The pivotal players were the Coxsackie B viruses, a group of enteroviruses. The coxsackieviruses themselves were discovered in 1948–1949 by Gilbert Dalldorf and Grace Sickles at the New York State Department of Health — named for the town of Coxsackie, New York, where the first isolate was obtained — during a search for the cause of poliomyelitis.

By the mid-to-late 1950s, the Coxsackie B viruses had been shown to be agents of severe inflammatory heart-muscle disease, and they became particularly associated with myocarditis in infants and children. For the first time, a specific, identifiable cause could be attached to cases that had previously been labelled "idiopathic" (of unknown cause). This was the moment Fiedler's hypothesized invisible microorganism acquired a name and a face, and it reframed acute myocarditis as, in many instances, a complication of a common viral infection rather than a mysterious disease of its own.

It is worth being precise about what this did and did not settle. Establishing that enteroviruses like Coxsackie B can cause myocarditis did not mean every case is viral, nor that the virus is always still present when the heart is biopsied; much of the muscle damage is now understood to come from the immune system's reaction. The viral discoveries opened a vast and still-active field — spanning many viruses and the autoimmune processes they can trigger — rather than closing the question. Later molecular techniques (from the 1980s onward) would let researchers hunt for viral genetic material directly in heart tissue, refining but not overturning the mid-century insight.

Back to Table of Contents

Standardizing Diagnosis: The Dallas Criteria (1987)

By the 1980s the field had a sharpened concept, a class of viral causes, and — thanks to the endomyocardial biopsy — the ability to sample living heart muscle through a catheter. What it still lacked was an agreed rulebook for reading those biopsies. Different pathologists looking at the same slide could reach different verdicts, so "myocarditis" still meant somewhat different things in different hospitals. The remedy was the Dallas criteria, a histopathological definition and classification formalized by a group of cardiovascular pathologists and published by H. T. Aretz and colleagues in 1987.

The Dallas criteria set a concrete, microscope-based standard: a diagnosis of myocarditis required an inflammatory cellular infiltrate of the myocardium together with damage or death (necrosis) of adjacent heart-muscle cells not typical of the damage caused by a blocked artery. The criteria also created intermediate categories — "borderline" myocarditis when inflammation was present without clear muscle-cell damage — and a vocabulary for describing follow-up biopsies as ongoing, resolving, or resolved. For the first time, the word had an operational, reproducible definition.

The Dallas criteria were a genuine milestone, and they remain a reference point, but their limitations are now well known and worth stating plainly. Because myocardial inflammation can be patchy, a biopsy needle may simply miss it, producing false-negative results; observers still disagree on borderline cases; and the criteria do not predict a patient's prognosis well. For these reasons, modern practice increasingly supplements (and sometimes replaces) biopsy with cardiac magnetic resonance imaging and immunohistochemical and molecular techniques — advances that build on the Dallas framework rather than discarding the principle it established: that calling something myocarditis should require demonstrable inflammation.

Back to Table of Contents

Toward the Modern Picture

Seen as a whole, the history of myocarditis is the history of a word being forced to earn its meaning. It began as a label (Sobernheim, ~1837; popularized by Virchow from 1858), ballooned into a catch-all that misclassified hypertensive and ischemic heart disease for decades, was given a sharp clinical core by Fiedler (1899), was separated from the non-inflammatory diseases once "cardiomyopathy" was named (Brigden, 1957), was tied to identifiable viral causes such as Coxsackie B from the mid-1950s, and was finally pinned to a reproducible tissue definition by the Dallas criteria (1987). Each step subtracted ambiguity.

That trajectory continues today. The understanding of cause has broadened well beyond a single virus to include many infectious agents, autoimmune and systemic inflammatory diseases, and adverse reactions to certain drugs and medical therapies, with the recognition that much of the heart damage is driven by the body's own immune response. The understanding of diagnosis has moved from autopsy, to biopsy, to non-invasive cardiac MRI that can reveal inflammation and scarring in a living patient without removing tissue. The result is a disease that can increasingly be recognized early and managed, rather than only named at the post-mortem table.

For the reader, the practical lesson of this history is one of healthy skepticism toward old certainties and confidence in hard-won definitions. When this page or any source says myocarditis, it should mean what Fiedler, Brigden, and the Dallas pathologists fought to make it mean: genuine inflammation of the heart muscle, demonstrated rather than assumed. The companion Myocarditis overview covers the modern clinical picture — symptoms, causes, diagnosis, and treatment — in detail.

Back to Table of Contents

Research Papers and References

The references below combine key peer-reviewed sources on the history, definition, and causes of myocarditis with curated PubMed topic-search links into the historical and clinical literature. Historical attributions (Sobernheim's coining of the term, Virchow's popularization) are drawn from the cited secondary reviews; primary nineteenth-century texts are named in the article as historical sources rather than as modern citations. DOI and PubMed links open in a new tab.

  1. Thiene G. Storytelling of Myocarditis. Biomedicines. 2024;12(4):832. — doi:10.3390/biomedicines12040832
  2. Aretz HT. Myocarditis: the Dallas criteria. Human Pathology. 1987;18(6):619-624. — doi:10.1016/s0046-8177(87)80363-5 · PMID:3297992
  3. Brigden W. Uncommon myocardial diseases: the non-coronary cardiomyopathies. The Lancet. 1957;273(7007):1179-1184. — doi:10.1016/s0140-6736(57)90159-9 · PMID:13492602
  4. Cooper LT Jr. Myocarditis. New England Journal of Medicine. 2009;360(15):1526-1538. — doi:10.1056/NEJMra0800028 · PMID:19357408
  5. Saphir O. Fiedler on acute interstitial myocarditis (1899) — historical translation and commentary — PubMed: Fiedler on acute interstitial myocarditis (1899)
  6. History of the term "myocarditis" (Sobernheim 1837; Virchow 1858) — PubMed: myocarditis history and terminology
  7. Fiedler's (acute isolated / idiopathic) myocarditis — PubMed: Fiedler myocarditis isolated idiopathic
  8. Coxsackie B virus and the viral causes of myocarditis — PubMed: coxsackievirus B myocarditis enterovirus
  9. Dallas criteria and the histopathologic diagnosis of myocarditis — PubMed: Dallas criteria endomyocardial biopsy
  10. Limitations of the Dallas criteria; cardiac MRI in myocarditis diagnosis — PubMed: Dallas criteria limitations and cardiac MRI
  11. Distinguishing myocarditis from cardiomyopathy; inflammatory cardiomyopathy — PubMed: myocarditis and inflammatory cardiomyopathy
  12. Virchow, cellular pathology, and nineteenth-century concepts of heart-muscle inflammation — PubMed: Virchow cellular pathology and myocarditis
  13. Over-diagnosis of "myocarditis" as a historical catch-all for non-valvular heart disease — PubMed: historical over-diagnosis of myocarditis

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents